Search Results - Amy Flynt
- Showing 1 - 3 results of 3
-
1
A Clinical Trial of Intravenous Peramivir Compared with Oral Oseltamivir for the Treatment of Seasonal Influenza in Hospitalized Adults by Michael G. Ison, David S.C. Hui, Kate Clezy, Brian J. O’Neil, Amy Flynt, P. Collis, Thomas Simon, W. James Alexander
Published 2012Artigo -
2
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell... by Ravi Salgia, R Weaver, Michael McCleod, John R. Stille, S. Betty Yan, Stephanie Roberson, John Polzer, Amy Flynt, Eyas Raddad, Victoria L. Peek, Sameera R. Wijayawardana, Suzane L. Um, Steve Gross, Mark C. Connelly, Carrie Morano, Madeline Repollet, Renouard Sanders, Kurt Baeten, David D’Haese, David R. Spigel
Published 2017Artigo -
3
Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy by Lindsay N. Alfano, Jay S. Charleston, Anne M. Connolly, Linda Cripe, C. Donoghue, Robert A. Dracker, J. Dworzak, Helen Eliopoulos, Diane E. Frank, Sarah Lewis, Karin K. Lucas, Jessie Lynch, Anthony J. Milici, Amy Flynt, Emily Naughton, Louise R. Rodino‐Klapac, Zarife Sahenk, Frederick J. Schnell, Geoffrey D. Young, Jerry R. Mendell, Linda Lowes
Published 2019Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Adverse effect
Alternative medicine
Ambulatory
Biochemistry
Biology
Biomarker
CXCR4
Cancer
Chemokine
Circulating tumor cell
Coronavirus disease 2019 (COVID-19)
Disease
Duchenne muscular dystrophy
Gastroenterology
Incidence (geometry)
Infectious disease (medical specialty)
Influenza A virus
Lung cancer
Metastasis
Neuraminidase inhibitor
Oncology
Optics
Oseltamivir
Pathology
Physics
Placebo
Predictive marker
Receptor